Our hypothesis to focus on SNHG6 for this study was based on the published literature supporting a role of SNHG6 in cancer drug resistance, coupled with the fact that its role specifically in tamoxifen resistance has never been elucidated. The gene discussed is SNHG6; the disease is cancer.